| Epidemiology and microbiology of surgical wound infections A Giacometti, O Cirioni, AM Schimizzi, MS Del Prete, F Barchiesi, ... Journal of clinical microbiology 38 (2), 918-922, 2000 | 476 | 2000 |
| EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility … JL Rodriguez-Tudela, MC Arendrup, F Barchiesi, J Bille, E Chryssanthou, ... Clinical Microbiology and Infection 14 (4), 398-405, 2008 | 469 | 2008 |
| Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts JL Rodriguez-Tudela, F Barchiesi, J Bille, E Chryssanthou, ... Clinical microbiology and infection 9 (8), i-viii, 2003 | 245 | 2003 |
| Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing AL Colombo, F Barchiesi, DA McGough, MG Rinaldi Journal of Clinical Microbiology 33 (3), 535-540, 1995 | 208 | 1995 |
| Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750 F Barchiesi, D Calabrese, D Sanglard, L Falconi Di Francesco, F Caselli, ... Antimicrobial agents and chemotherapy 44 (6), 1578-1584, 2000 | 204 | 2000 |
| International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole … A Espinel-Ingroff, F Barchiesi, M Cuenca-Estrella, MA Pfaller, M Rinaldi, ... Journal of clinical microbiology 43 (8), 3884-3889, 2005 | 201 | 2005 |
| Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical … F Barchiesi, AL Colombo, DA McGough, MG Rinaldi Journal of Clinical Microbiology 32 (10), 2494-2500, 1994 | 161 | 1994 |
| Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing … M Cuenca-Estrella, CB Moore, F Barchiesi, J Bille, E Chryssanthou, ... Clinical microbiology and infection 9 (6), 467-474, 2003 | 158 | 2003 |
| Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital A Bedini, C Venturelli, C Mussini, G Guaraldi, M Codeluppi, V Borghi, ... Clinical microbiology and infection 12 (1), 75-80, 2006 | 150 | 2006 |
| Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis F Barchiesi, E Spreghini, S Tomassetti, A Della Vittoria, D Arzeni, ... Antimicrobial agents and chemotherapy 50 (8), 2719-2727, 2006 | 129 | 2006 |
| How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) MC Arendrup, N Friberg, M Mares, G Kahlmeter, J Meletiadis, J Guinea, ... Clinical Microbiology and Infection 26 (11), 1464-1472, 2020 | 126 | 2020 |
| In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa A Giacometti, O Cirioni, F Barchiesi, M Fortuna, G Scalise Journal of Antimicrobial Chemotherapy 44 (5), 641-645, 1999 | 125 | 1999 |
| In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically A Giacometti, O Cirioni, F Barchiesi, MS Del Prete, M Fortuna, F Caselli, ... Antimicrobial agents and chemotherapy 44 (6), 1694-1696, 2000 | 123 | 2000 |
| Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans F Barchiesi, AM Schimizzi, F Caselli, A Novelli, S Fallani, D Giannini, ... Antimicrobial agents and chemotherapy 44 (9), 2435-2441, 2000 | 117 | 2000 |
| EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents MC Arendrup, J Meletiadis, JW Mouton, J Guinea, M Cuenca-Estrella, ... Clinical microbiology and infection 22 (6), 571. e1-571. e4, 2016 | 113 | 2016 |
| In vitro activity of itraconazole against fluconazole-susceptible and-resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus F Barchiesi, AL Colombo, DA McGough, AW Fothergill, MG Rinaldi Antimicrobial agents and chemotherapy 38 (7), 1530-1533, 1994 | 113 | 1994 |
| In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics A Giacometti, O Cirioni, F Barchiesi, G Scalise Diagnostic microbiology and infectious disease 38 (2), 115-118, 2000 | 110 | 2000 |
| Antimicrobial activity of polycationic peptides A Giacometti, O Cirioni, F Barchiesi, MS Del Prete, G Scalise Peptides 20 (11), 1265-1273, 1999 | 109 | 1999 |
| In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates of Candida Species F Barchiesi, AM Schimizzi, AW Fothergill, G Scalise, MG Rinaldi European Journal of Clinical Microbiology and Infectious Diseases 18, 302-304, 1999 | 108 | 1999 |
| In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles F Barchiesi, L Falconi Di Francesco, G Scalise Antimicrobial Agents and Chemotherapy 41 (8), 1812-1814, 1997 | 108 | 1997 |
